You are on the new improved site. You can view the old site in view-only mode here until June 27, 2026

Filter Results

Select search scope: search across all journals or within the current journal

Search this journal

Enter search terms…

Advanced search

/

About

About Sage
About Sage Journals
Privacy Policy
Terms of Use
Contact Us
Help

Information for

Authors
Editors
Librarians
Researchers
Reviewers
Frequently asked questions

All content on this site: Copyright © 2026 Sage Publications. All rights reserved. This website is technically supported and operated by China National Publications Import and Export (Group) Co., Ltd. 京ICP备09090397号-11

Letter to the editor

Journal of Oncology Pharmacy Practice

Impact Factor: 0.9 / 5-Year Impact Factor: 1.2

Journal Homepage Submission guidelines

Restricted access

Other

First published online June, 2010

Letter to the editor

and

Volume 16, Issue 2

https://doi.org/10.1177/1078155209346072

Abstract

Get full access to this article

View all access options for this article.

References

1.

Howell JE , Szabatura AH , Seung AH , Nesbit SA Characterization of the occurrence of ifosfamide-induced neurotoxicity with concomitant aprepitant. J Oncol Pharm Practice 2008; 14: 157-62.

Browse journal

Current issue OnlineFirst All issues

Similar articles

Retricted access

The effects of a palliative care program on antidepressant use and continuing maintenance medications in near end-of-life oncology patients (the HEALED study)

Retricted access

Conference report: Oncology pharmacoeconomics The Seventh International Symposium on Oncology Pharmacy Practice,Prague,Czech Republic,April 5-8,2000

Retricted access

Transfusions increase with nationally driven reimbursement changes of erythropoiesis stimulating agents for chemotherapy-induced anemia

Retricted access

Incidence,outcome and predictors of bleomycin pulmonary toxicity in a university hospital in Oman